These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
249 related articles for article (PubMed ID: 7945422)
1. Irreversible blockade of high-affinity choline uptake in rat brain by N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline (EEDQ). Vickroy TW; Malphurs WL Biochem Pharmacol; 1994 Sep; 48(6):1281-7. PubMed ID: 7945422 [TBL] [Abstract][Full Text] [Related]
2. Effects of in vivo and in vitro treatments with N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline on putative muscarinic receptor subtypes in rat brain. Norman AB; Creese I Mol Pharmacol; 1986 Aug; 30(2):96-103. PubMed ID: 3755499 [TBL] [Abstract][Full Text] [Related]
3. Effects of acetylethylcholine mustard on [3H]quinuclidinyl benzilate binding and acetylcholine release in rat brain synaptosomes. Meyer EM; Otero DH; Morgan E; Marchand S; Baker SP J Neurochem; 1987 Feb; 48(2):477-82. PubMed ID: 3794717 [TBL] [Abstract][Full Text] [Related]
5. Effects of chlorpyrifos on high-affinity choline uptake and [3H]hemicholinium-3 binding in rat brain. Liu J; Pope CN Fundam Appl Toxicol; 1996 Nov; 34(1):84-90. PubMed ID: 8937895 [TBL] [Abstract][Full Text] [Related]
6. Irreversible and quaternary muscarinic antagonists discriminate multiple muscarinic receptor binding sites in rat brain. Norman AB; Eubanks JH; Creese I J Pharmacol Exp Ther; 1989 Mar; 248(3):1116-22. PubMed ID: 2703964 [TBL] [Abstract][Full Text] [Related]
7. Postnatal development of muscarinic autoreceptors modulating acetylcholine release in the septohippocampal cholinergic system. I. Axon terminal region: hippocampus. Goldbach R; Allgaier C; Heimrich B; Jackisch R Brain Res Dev Brain Res; 1998 Jun; 108(1-2):23-30. PubMed ID: 9693780 [TBL] [Abstract][Full Text] [Related]
8. Selectivity of hemicholinium mustard, an affinity ligand, for the high-affinity choline transport system. Gylys KH; Abdalah I; Jenden DJ Neuropharmacology; 1997; 36(11-12):1741-6. PubMed ID: 9517446 [TBL] [Abstract][Full Text] [Related]
9. Regulation of rat brain synaptosomal [3H]hemicholinium-3 binding and [3H]choline transport sites following exposure to choline mustard aziridinium ion. Ferguson SS; Rylett RJ; Collier B J Neurochem; 1994 Oct; 63(4):1328-37. PubMed ID: 7931285 [TBL] [Abstract][Full Text] [Related]
10. MKC-231, a choline uptake enhancer: (3) Mode of action of MKC-231 in the enhancement of high-affinity choline uptake. Takashina K; Bessho T; Mori R; Kawai K; Eguchi J; Saito K J Neural Transm (Vienna); 2008 Jul; 115(7):1037-46. PubMed ID: 18461273 [TBL] [Abstract][Full Text] [Related]
11. Differential sensitivity of [3H]7-OH-DPAT-labeled binding sites in rat brain to inactivation by N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline. Levant B Brain Res; 1995 Nov; 698(1-2):146-54. PubMed ID: 8581473 [TBL] [Abstract][Full Text] [Related]
12. Irreversible modification of the voltage-sensitive calcium channel by N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline (EEDQ). Gopalakrishnan M; Triggle DJ Biochem Pharmacol; 1990 Jul; 40(2):327-32. PubMed ID: 1973894 [TBL] [Abstract][Full Text] [Related]
13. Behavioral and radioligand binding evidence for irreversible dopamine receptor blockade by N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline. Hamblin MW; Creese I Life Sci; 1983 May; 32(19):2247-55. PubMed ID: 6133202 [TBL] [Abstract][Full Text] [Related]
14. N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline (EEDQ) administration for studies of 5-HT1A receptor binding site inactivation and turnover. Keck BJ; Lakoski JM Brain Res Brain Res Protoc; 1997 Oct; 1(4):364-70. PubMed ID: 9384817 [TBL] [Abstract][Full Text] [Related]
15. Alkylation of rat dopamine transporters and blockade of dopamine uptake by EEDQ. Tarazi FI; Kula NS; Zhang K; Baldessarini RJ Neuropharmacology; 2000 Aug; 39(11):2133-8. PubMed ID: 10963756 [TBL] [Abstract][Full Text] [Related]
16. Differential effects of N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline (EEDQ) on various 5-HT receptor binding sites in the rat brain. Gozlan H; Laporte AM; Thibault S; Schechter LE; Bolaños F; Hamon M Neuropharmacology; 1994; 33(3-4):423-31. PubMed ID: 7984280 [TBL] [Abstract][Full Text] [Related]
17. Differential effects of the alkylating agent N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline on brain alpha 2-adrenoceptors and I2-imidazoline sites in vitro and in vivo. Miralles A; Ribas C; Olmos G; García-Sevilla JA J Neurochem; 1993 Nov; 61(5):1602-10. PubMed ID: 8228980 [TBL] [Abstract][Full Text] [Related]
18. MKC-231, a choline uptake enhancer: (2) Effect on synthesis and release of acetylcholine in AF64A-treated rats. Takashina K; Bessho T; Mori R; Eguchi J; Saito K J Neural Transm (Vienna); 2008 Jul; 115(7):1027-35. PubMed ID: 18446264 [TBL] [Abstract][Full Text] [Related]
19. In vitro and in vivo irreversible blockade of cortical S2 serotonin receptors by N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline: a technique for investigating S2 serotonin receptor recovery. Battaglia G; Norman AB; Newton PL; Creese I J Neurochem; 1986 Feb; 46(2):589-93. PubMed ID: 2934516 [TBL] [Abstract][Full Text] [Related]
20. Amyloid beta-peptide inhibits high-affinity choline uptake and acetylcholine release in rat hippocampal slices. Kar S; Issa AM; Seto D; Auld DS; Collier B; Quirion R J Neurochem; 1998 May; 70(5):2179-87. PubMed ID: 9572306 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]